Emergen Research Logo

Rising focus on genetic testing and personalized medicine are key factors driving market revenue growth

VANCOUER, BC, CANADA, May 12, 2022 /EINPresswire.com/ -- The global biobanking market size is expected to reach USD 67.90 Billion in 2030 and register a revenue CAGR of 8.6% over the forecast period, according to latest analysis by Emergen Research. Increasing genomic research activities and investment in R&D by major companies is driving global biobanking market revenue growth. Surge in research activities of regenerative medicines, stem cell therapeutics, and cell and gene therapy is also driving revenue growth of the global market.

Biobanking market revenue growth is also driven by increase in application of bio-banked samples. Biobanks focusing on plants, animals, and microbes are evolving rapidly. Different types of biobanks are gaining traction, such as disease-centric biobanks, population-based banks, DNA/RNA banks, genetic banks, tissue banks, blood banks, virtual biobanks, stem cell banks, microbiome banks, and others, which is driving market revenue growth. Biobanks enable access to large pool of high-quality samples and associated data.

𝐅𝐫𝐞𝐞 𝐏𝐃𝐅 𝐒𝐚𝐦𝐩𝐥𝐞 𝐛𝐫𝐨𝐜𝐡𝐮𝐫𝐞 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 @ https://www.emergenresearch.com/request-sample/926

biobank helps to provide new insights into genetic components of human disease and is creating an automated and personalized approach to healthcare. Rise in population and increase in health awareness missions and programs across the globe is contributing to market growth. One of the important aspects of biobanking is increased accuracy in pharmaceutical studies..

𝐁𝐢𝐨𝐛𝐚𝐧𝐤𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰 :

According to Emergen Research Biobanking Market Size – USD 29.79 Billion in 2020, Market Growth – at a CAGR of 8.6%, Market Trends – Advancements in technology

Biobanking Market in Asia Pacific is expected to register a rapid revenue growth rate during the forecast period owing to improvements in lifescience research infrastructure and rising government investment in the fields of biotechnology, pharmaceuticals, and biomedicals. Increasing global population and expansion of biobanks in China, Japan, South Korea, Singapore, Australia, and India is contributing significantly to market revenue growth.

𝐀𝐥𝐥 𝐫𝐞𝐩𝐨𝐫𝐭 𝐞𝐱𝐩𝐥𝐚𝐧𝐚𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐢𝐧𝐝𝐞𝐱 𝐁𝐫𝐨𝐰𝐬𝐞 @ https://www.emergenresearch.com/industry-report/biobanking-market

The Biobanking Market report takes a closer view of the global Biobanking Market share, estimated growth rate, future market trends, entry-level barriers, fundamental market drivers, restraints, challenges, and opportunities. The report clearly defines Biobanking Market position on a global level. The detailed insights into the market’s geographical spectrum offered by the report make it an excellent source of knowledge about the Biobanking Market .

𝐒𝐞𝐫𝐯𝐢𝐜𝐞𝐬 𝐬𝐞𝐠𝐦𝐞𝐧𝐭 :

Services segment is expected to register rapid revenue growth rate during the forecast period owing to rising demand for storage services. Increase in stem cell biobanking is gaining traction in recent years due to rising awareness regarding therapeutic benefits of stem cells and increased investment in stem cell-based research. Increasing number of clinical trials for development of regenerative medicines to treat rare and chronic diseases is also driving revenue growth of this segment.

𝐊𝐞𝐲 𝐩𝐚𝐫𝐭𝐢𝐜𝐢𝐩𝐚𝐧𝐭𝐬 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 :

Biobank Limited, Medizinische Universitat Graz, Hamilton Company, ASKION, Azenta Life Sciences, Qiagen, Promega Corporation, Integrated Biobank of Luxembourg (IBBL), Isenet Biobanking, and Thermo Fisher Scientific, Inc
Scope of the Global Biobanking Market Report :

The report performs an accurate estimation of the growth prospects of the different market segments by studying the current market scenario, past performance, demand and supply ratio, production, consumption, sales, and revenue generation of the key players in the upcoming years. The market segmentation provides a 360° view of the Biobanking Market industry, which turns out to be beneficial for readers interested in this sector.

The study is inclusive of a profound analysis of this business sphere focuses on the overall remuneration of the market over the projected period. The study also includes significant information pertinent to the Biobanking Market industry, particularly the current COVID-19 scenario. Exhaustive coverage of the COVID-19 impact on the Biobanking Market industry is a major attraction of the report.

𝐄𝐦𝐞𝐫𝐠𝐞𝐧 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐡𝐚𝐬 𝐬𝐞𝐠𝐦𝐞𝐧𝐭𝐞𝐝 𝐭𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐁𝐢𝐨𝐛𝐚𝐧𝐤𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 𝐀𝐫𝐞 𝐚𝐬 :

Emergen Research has segmented the global biobanking market on the basis of product & services, sample type, storage type, application, and region:

Product & Services Outlook (Revenue, USD Billion; 2018–2030)
Equipment
Storage Equipment
Sample Transport Equipment
Sample Processing Equipment
Sample Analysis Equipment
Consumables
Collection Consumables
Storage Consumables
Processing Consumables
Analysis Consumables
Services
Supply Services
Processing Services
Storage Services
Transport Services
Software

Sample Type Outlook (Revenue, USD Billion; 2018–2030)
Biological Fluids
Human Tissues
Blood Products
Nucleic Acids
Human Waste Products
Cell Lines

Storage Type Outlook (Revenue, USD Billion; 2018–2030)
Automated Storage
Manual Storage

Application Outlook (Revenue, USD Billion; 2018–2030)
Regenerative Medicine
Life Science Research
Clinical Research

𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐁𝐢𝐟𝐮𝐫𝐜𝐚𝐭𝐢𝐨𝐧 𝐨𝐟 𝐭𝐡𝐞 𝐁𝐢𝐨𝐛𝐚𝐧𝐤𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐜𝐥𝐮𝐝𝐞𝐬:

North America (U.S., Canada)
Europe (U.K., Italy, Germany, France, Rest of EU)
Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

𝐖𝐡𝐚𝐭 𝐢𝐬 𝐭𝐡𝐞 𝐚𝐢𝐦 𝐨𝐟 𝐭𝐡𝐞 𝐫𝐞𝐩𝐨𝐫𝐭?

Based on various indicators, the Year-on-Year growth (%) and compound annual growth rate (CAGR) for the given forecast period is offered.

An overview of the Biobanking Market based on geographical scope, market segmentation and financial performance of key players is presented in the report.

The report presents current trends in the industry and future scope of the Biobanking Market in North America, Asia Pacific, Europe, Latin America and Middle East and Africa.

The various parameters accelerating the growth of Market are incorporated in the research report.

The report analyses growth rate, market size and valuation of the Market during the forecast period.

𝐃𝐢𝐫𝐞𝐜𝐭𝐥𝐲 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 @ https://www.emergenresearch.com/select-license/926

Thank you for reading our report on global Biobanking Market . Please connect to us to know more about the customization feature to get a customized report as per you requirement.

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐌𝐨𝐫𝐞 𝐄𝐦𝐞𝐫𝐠𝐞𝐧 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 @

High-performance Liquid Chromatography (HPLC) Market @ https://www.emergenresearch.com/industry-report/high-performance-liquid-chromatography-market

Organs-on-Chips Market @ https://www.emergenresearch.com/industry-report/organs-on-chips-market

Compound Management Market @ https://www.emergenresearch.com/industry-report/compound-management-market

Bariatric Surgery Market @ https://www.emergenresearch.com/industry-report/bariatric-surgery-market

Autoinjectors Market @ https://www.emergenresearch.com/industry-report/autoinjectors-market

Drug Infusion Systems Market @ https://www.emergenresearch.com/industry-report/drug-infusion-systems-market

𝐀𝐛𝐨𝐮𝐭 𝐮𝐬 :

Emergen Research reports, customized research reports and consulting services. company. Our solutions focus solely on your purpose of finding, targeting, and analyzing consumer behavior changes across demographics and industries, and helping customers make smarter business decisions. We provide market intelligence research that ensures relevant and fact-based research across multiple industries including healthcare, touchpoints, chemicals, tangibles and energy. We constantly update our research products to keep our clients aware of the latest trends in the market.

Eric Lee
Emergen Research
+91 90210 91709
sales@emergenresearch.com
Visit us on social media:
Facebook
Twitter
LinkedIn

The global biobanking market size is expected to reach USD 67.90 Billion in 2030 and register a revenue CAGR of 8.6% over the forecast period

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.